Larvol Delta - Alzinova-receives-approval-to-start-the-rst-clinical-study-with-the-oligomerspecic-ALZ101-vaccine-in-patients-with-Alzheimer39s-disease

ALZ-101 - Alzinova

https://www.prnewswire.com/news-releases/alzinova-receives-approval-to-start-the-first-clinical-study-with-the-oligomer-specific-alz-101-vaccine-in-patients-with-alzheimers-disease-301388852.html

Sep 30, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next